Relief Therapeutics Holding AG (RLFTF)

[randychub]

REGN will probably beat them done. So which MAB do you think is better?

If the first MAB used on a patient fails, will the patient be well enough to use the 2nd MAB or will the move to Dex or RLF-100.

Also if the RLF-100 inhaler works do you think any of the MABs will compete?


I think Relief should run a phase 2 with no placebo ARM with the inhaler at the same time they start the phase 3 with placebo so they can see right away how well it works